Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
2015 · BMC Research Notes · 28 citations
https://doi.org/10.1186/s13104-015-1231-8
É
Émilie Hénin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
1.0K
Citations
19
h-index
33
i10-index
Émilie Hénin is an academic researcher from Calvagone (France). The author has contributed to research in topics: Pharmaceutical studies and practices & Cancer Genomics and Diagnostics & Statistical Methods in Clinical Trials. The author has an h-index of 19, co-authored 63 publications.
ORCID: 0000-0001-7478-2154Papers by this author
worksEfficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease
2018 · Journal of Lipid Research · 27 citations
https://doi.org/10.1194/jlr.m085043
Model-based design of rituximab dosing optimization in follicular non-hodgkin lymphoma
2011 · HAL (Le Centre pour la Communication Scientifique Directe) · 1 citations
2009 - Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin lymphoma
2009 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Comparing probabilistic and descriptive analyses of time-dose-toxicity relationship for determining no-observed-adverse-effect level in drug development
2015 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat